Founders powering the next wave of health innovation.

Congratulations to founders on recently completing MedTech Actuator – Asia Pacific’s MedTech catalyst.

We are proud to support our fifth cohort in radically accelerating their medical, health or biological technology prototype or proof-of-concept to improve and save lives.

Thank you so much to every founder for being a part of the industry-led MedTech Actuator. We are delighted to have you on board in the MedTech Actuator™ innovation ecosystem for life and can’t wait to see where your journey takes you next.

Congratulations to our new MedTech Actuator alumni

Congratulations to all cohort five founders and teams including:

  • Beta Medtech – Edison Bellarmin, Thomas Ooi | Smart patch for the detection and monitoring of pressure ulcers.
  • ChezLeon – Cheryl Pollock | Passive massage wear for treatment of lymphoedema as a side effect of cancer treatment.
  • CPAP Buddy by Tasmanian Medical Innovations – Kathleen Lim, Lachlann McLeod, Cameron Keating, Peter Dargaville, Andrew Marshall | A continuous monitoring system that makes breathing support safer for preterm infants.
  • Diag-Nose Medical – Eldin Rostom, David Yen, Brian Wang, Josie Xu | Non-invasive diagnostics for better rhinology treatments.
  • EloCare – Mabel Nguyen, Fandi Peng | Innovating in the internet of medical things and AI technology to help people live longer and age gracefully.
  • Gabriel – Maria Crews, Nick Crews | Making it possible for seniors to live better for longer.
  • HiCura Medical – Cailin Ng, Yusong Leng | AI technology reducing risks and discomfort for patients during childbirth.
  • Medicsen | Needle-free smart patch for painless drug delivery.
  • Onward Health Research – Martin Lim | A digital health platform enabling world-class clinical research in emerging markets.
  • PhysiPal – Aaya Hakeem, Ahmed Hakeem | A device and app combination that allows patients to take charge of their physiotherapy rehabilitation at home.
  • Recovery App – Allan Molloy, Myles Coolican, Tony Nicol | Digital health platform to optimise outcomes and reduce costs associated with major orthopaedic surgery.
  • Repli-med – Zoe Keon-Cohen, Thomas Sutton | 3D printed models to train and help prepare surgeons and anaesthetists for eye and spine procedures.
  • TuCann – Maryam Soomro, Kenneth Wong, Santiago Beltran Diaz | Cannula solution, simplifying the cannulation process and decreasing likelihood of infection

Where to from here?

Founders can now tap into MedTech Actuator’s unrivalled network – including 85 partners and 75 mentors from some of the largest names in health innovation spanning multi-national corporations, hospitals and clinicians, investor groups and VCs, professional service partners, universities and research institutions, and product development firms.

They join an alumni network of the brightest emerging startups from across Asia Pacific, and our networks are their networks as they scale up, prepare for exit and beyond.

About MedTech Actuator

The MedTech Actuator’s specialised acceleration model surrounds startups with the ecosystem support they need to bring their MedTech, HealthTech or BioTech innovation to the patients and clinicians who need it most.

Through MedTech Actuator’s intensive mentorship, industry collaboration, up to AUD$200K initial capital injection and capital raising support, the founders can achieve in 15 months what can typically take 3 years or more.

Embedded in the MedTech Actuator™ ecosystem, founders radically advance their technology development, raise seed capital, and build critical business and management skills. They become primed and ready to grow their venture even further – including raising series A funding, commencing clinical trials, gaining regulatory approvals, and moving to at-scale manufacturing, and market launch.

More on MedTech Actuator, or subscribe below for news on upcoming intakes.

Our village is raising MedTech’s next wave of innovators.

Thank you to health innovation experts from across Asia Pacific and the US who recently shared their industry insights and knowledge through MedTech Actuator sprints with the region’s best emerging health entrepreneurs.

As Asia Pacific’s MedTech catalyst, MedTech Actuator is a 15-month, industry-led, venture-backed program that aggressively funds and accelerates medical, health and biological technology startups. Our latest MedTech Actuator cohort is driving innovation for patients and clinicians who need it most, in diverse fields spanning IVF, prosthetics, rehabilitation and more.

The sprints: relentless execution towards market success.

Through our recent MedTech Actuator sprints, founders developed expertise in business models, pitching, customer validation, IP, regulations, reimbursement, clinical trials in Australia, Singapore, the US, and the EU.

This expertise will be crucial to their success in determining a pathway to market, including how long it will take to secure their first paying customer.

With these important foundations in place MedTech Actuator startups are now working to address critical risk areas, before ramping up commercialisation activities.

Our village, helping to take founders there.

It takes a village to raise a startup and health innovation is no exception. These latest MedTech Actuator sprints would not have been possible without the support of our village.

Our sincere thanks to all the people and companies that have contributed to our latest cohort so far:

  • Alex Newton – NAVI
  • Tony Sinclair – Impactor
  • Gemma and Lucas Testro – SONDO
  • Matt Godden – Australian Healthcare Solutions
  • Nairy Baghdikian – Cogentum
  • Penelope Lane – SCALE
  • Michelle Gallaher – Opyl
  • Stefaan Van Der Meulen – Syntactx
  • Nick Opie – Synchron
  • Jean-Nicolas Boudaud – Brandwood
  • Marco Kalms – Kalms Consulting
  • Tom Hughes – LabCorp
  • Lee Phin Peng, Hee Choon – Singapore Biodesign
  • Amrish Nair – Biorithm
  • Jason Lim, Yang Jie Tan – Stendard
  • Lawrence Ho and Rina Lim – NUHS
  • Cher Hwa Teo, Ee Lim, Michael Ho – NHIC Singapore
  • Tan Cher Heng – NHG

Our village spans far and wide across the globe. We also extend our sincere thanks to MedTech Actuator partners for their generous contribution.

  • Jarred Roache – Roache Design
  • Matthew Gould, Leah Han, Dr Anna Bellamy-McIntyre, Matt Cary, Joseph Barker – EY
  • Rachel Hooke, Eddie Walker – FB Rice
  • Jonathan Kelp, Simone Mitchell & Kristi Geddes – Minter Ellison
  • Natalie Lawandi, Rashmi Joglekar – MedTronic
  • Dr Megan Robertson – St Vincent’s
  • Chris Rupp, Stefaan van der Meulen – NAMSA
  • Frank Jaskulke – Medical Alley
  • Anh Bourcet – J&J Singapore
  • Johanes Candra, Sherilyn Chan – EY Singapore
  • Delon Toh – ESG

We are grateful for everyone’s time, drive, energy, and enthusiasm – we could not do this without you and are excited to support the continued growth of our founders.

Find out more about MedTech Actuator.

Meet the next MedTech Actuator Menzies Scholars

The MedTech Actuator and Menzies Foundation are thrilled to announce the second cohort of MedTech Actuator Menzies Scholarships.

After an overwhelming response to our call for applications – we were three times oversubscribed – MedTech Actuator and the Menzies Foundation have narrowed it down to an inspiring cohort of researchers and scientists who are ready to transform their impact.

Embarking on a two-month scholarship, recipients will gain insight from industry experts, learn alongside Australia’s best emerging entrepreneurs, access exclusive industry events and network with a dynamic cohort of innovators. The scholarship supports emerging scientists and researchers on their pathway to an impact-driven career fusing science, research, and entrepreneurship.

Introducing the new scholars

The MedTech Actuator Menzies Scholarship cohort are passionate about developing healthcare solutions that improve and save lives. Their diverse expertise spans diabetes, cancer treatments, precision medicine, wellbeing devices, gene therapy, neonatal care and more. 

Scholarship recipients include:

Dr Sebastian Corlette, Anaesthetist, Royal Children’s Hospital and PhD Candidate, Murdoch Children’s Research Institute and the University of Melbourne.

Project: Developing a new sensor for high-quality, long-term electroencephalogram (EEG) measurement in young babies.

Darcy Dunn-Lawless, Master of Engineering (Biomedical), Flinders University.

Project: Developing a new medical implant for cancer patients who have had orthopaedic surgery.

Adaeze Ekwe, PhD Candidate, QIMR Berghofer Medical Research Institute and Queensland University of Technology.

Project: Developing a novel cellular therapy for graft-versus-host disease using genetically modified regulatory T cells.

Erin Humphries, Research Assistant at Children’s Medical Research Institute and Masters by Research Student at the University of Sydney.

Project: Discovering new biological insights into cancer.

Ismat Kabbara, Co-founder, Synbiote and Master of Science in Anatomy, University of NSW.

Project: Making biological materials for pharmaceuticals more efficient to manufacture and affordable.

Marta Orlowska, PhD Candidate, QIMR Berghofer Medical Research Institute and Queensland University of Technology.

Project: Investigating metabolic shifts at a cellular level, through time of day dependent influencing factors.

Dr Rowan Page, Lecturer and Industrial Design Program Director, Monash University.

Project: Developing a wearable light sensing device to guide people toward healthier light exposure patterns.

Dr Anushi Rajapaksa, Senior Research Officer, Murdoch Children’s Research Institute and Founder, Think Project Global.

Project: Developing rapid, life-saving drug delivery for children with infectious respiratory disease.

Rance Brennan B. Tino, PhD Candidate, Peter MacCallum Cancer Centre and RMIT Centre for Additive Manufacturing, RMIT University.

Project: 3D Printing of bespoke phantoms for treatment planning verifications in radiotherapy

April Van Der Kamp, PhD Candidate, Flinders University.

Project: Developing novel diabetic foot ulcer treatments.

The MedTech Actuator Menzies Scholarship Experience

Joining MedTech Actuator Origin, scholars will be exposed to the world of entrepreneurship and see what it takes to commercialise successful healthcare ventures. Topics covered across workshops and an industry-led intensive sprint will include intellectual property, pitching, business modelling, pathways-to-market, regulatory strategies, market analysis and more.

MedTech Actuator Menzies Scholarships will provide recipients with a $1,000 stipend and a pivotal learning experience to amplify their careers as champions for impact-driven healthcare innovation.

Follow their journey – or get ready to become a scholar

Sign up to our newsletter below and connect with us on Twitter and LinkedIn to follow the journey of scholars – and to find out how to be a 2022 MedTech Actuator Menzies Scholar.

The MedTech Actuator Menzies Scholarship is supported by the Menzies Foundation as part of their Entrepreneurship in Science mission in partnership with the MedTech Actuator.

MedTech Actuator Menzies Fellowships now open

Are you a high-potential scientist or researcher working with MedTech, BioTech or HealthTech innovations? Are you interested in exploring entrepreneurship and commercialisation? Do you have a research project with market translation potential?

Applications are now open for 2022 MedTech Actuator Menzies Fellowships. Two high-potential medical or scientific researchers will each receive a tailored MedTech Actuator experience. This includes mentorship from industry experts, networking opportunities, exclusive industry events, and a $20,000 stipend.

Apply now for 2022 MedTech Actuator Menzies Fellowships!

The MedTech Actuator Menzies Fellowship exposes senior researchers to entrepreneurship, commercialisation and the startup ecosystem to unlock the potential of Australia’s world-class research.

“We know that there is great work being done by researchers in Australia – particularly in the areas of human health and medicine. We want to support this talent by giving researchers access to commercialisation expertise so that they can share their work with the people who need it most – patients and clinicians,” says MedTech Actuator CEO, Dr Buzz Palmer.

“The MedTech Actuator Menzies Fellowship will provide high-potential scientists with a strong grounding in the elements of commercialisation. Most importantly, it will provide access to founders and our extensive ecosystem of partners – a network that spans hospitals, product development firms, multinational MedTech corporations and investors,” says Dr Palmer.

The MedTech Actuator Menzies Fellowship is a partnership between the Menzies Foundation and MedTech Actuator, which supports the scientific community’s commercialisation capacity by facilitating knowledge transfer from industry to researchers. 

“We are passionate about investing in our country’s future science leaders and giving them the runway to ensure that their research has an impact in the world. We look forward to sharing their entrepreneurial journey,” Menzies Foundation CEO Liz Gillies said.

How it works

Initially, Fellows will embark on 6 months of mentorship – working with experts within the MedTech Actuator focusing on both technology and personal development. 

During the second 6-month phase, Fellows will take part in a tailored version of our flagship, industry-led accelerator. They’ll learn how to navigate key inflection moments in the commercialisation journey, from developing regulatory and reimbursement strategies to product development, approaching investors and building a team. Importantly, they’ll learn with – and from – other MedTech, HealthTech and BioTech founders from across Asia Pacific.

Eligibility

To be eligible researchers must be working in a senior position in areas of health, medical or biotechnology research at an Australian university or institution. Applicants must also have 15+ years of experience across research and scientific positions.

Fellows must have employer approval to be absent for:

  • Approx. 10 hrs during the first 6-month phase 2022 (Jan – June, 2022).
  • Approx. 2-3 days per month during the second 6-month phase (July – Dec, 2022).
The MedTech Actuator Menzies Fellowship can be undertaken while working.

Key dates

  • September 6 – October 15, 2021: MedTech Actuator Menzies Fellowship applications open
  • November 11, 2021: MedTech Actuator Menzies Fellowship selection interviews
  • July – December 2022: MedTech Actuator – Asia Pacific’s MedTech accelerator – sessions on commercialisation (first week of every month)
  • December, 2022: Wrap up of the Fellowship

The MedTech Actuator Menzies Fellowship is supported by the Menzies Foundation as part of their Entrepreneurship in Science mission in partnership with the MedTech Actuator.

Apply now

If you are a career researcher or if you know someone who might be interested, find out more about the Fellowship and transform your research potential today!

Apply now

MedTech Actuator Origin is back – apply today!

Are you an aspiring entrepreneur with a MedTech, BioTech or HealthTech startup idea? Apply now for the 2021 MedTech Actuator Origin!

All superheroes have a beginning and so do startup founders. Transform your idea or research with MedTech Actuator Origin – a two month early-stage entrepreneurship competition that will help you translate your concept into an impact orientated health venture.

Whether you’re a researcher, scientist, clinician, student or garage inventor, MedTech Actuator Origin is looking for passionate entrepreneurs to transform healthcare. Apply today!

The MedTech Actuator Origin experience

Delivered in-person and online, MedTech Actuator Origin is open to Australian health entrepreneurs and will run from October to December 2021. Our experts will pressure test your idea and expose you to the world of startups through:

  • Workshops – gain insight into what it takes to protect your idea and learn how to craft a prize-winning pitch.
  • Rapid Fire Round – pitch your concept to a panel of industry leaders and peers, putting your idea and pitching skills to the test.
  • Mentoring – receive tailored mentorship from industry experts who will help you bring your MedTech, BioTech or HealthTech innovation to market.
  • Access to the MedTech Actuator knowledge hub – commercialisation 101 curated content for researchers and medical professionals turned entrepreneurs.
  • Sprint Intensive – access a 3-day sprint intensive where you’ll dive into the world of entrepreneurship and commercialisation, including workshops, founder stories, panel discussions, activities, and heaps more!
  • Pitch Competition – bring together all your ideas in a short, 3-minute pitch to a select panel of judges to earn one of three places at the MedTech Actuator Showcase, a $15k cash prize and over $5k worth of in-kind prizes.
  • MedTech Actuator Showcase – pitch your idea to the ecosystem at the MedTech Actuator Showcase, a black-tie gala event for investors, industry-leaders, corporate partners and global MedTech companies.

The Origin winner will take home $15k in cash and have the opportunity to be fast-tracked through the application process for the MedTech Actuator – Asia Pacific’s MedTech accelerator – moving your product even closer to market.

Meet Amy Yu – MedTech Actuator Origin alumna

Photo of Amy Yu in MedTech Actuator superhero tee, Melbourne lane way by night.
Amy Yu, MedTech Actuator Origin alumna & Ventora Medical CTO.

“Ventora Medical spun out of the BioDesign Innovation program at the University of Melbourne. As soon as we graduated in 2018, we entered MedTech Actuator Origin. For Ventora, MedTech Actuator Origin really was the first point of validation from the MedTech entrepreneurial community in Melbourne. We were lucky enough to get through each round and be selected as a top five finalist.

You don’t know what you don’t know, and MedTech Actuator Origin taught us just that. At the bootcamps we took that all in, like sponges, and learnt so much from MedTech Actuator. This was backed up by networking with people who helped us achieve all of those unknowns and hit milestones.”

– Amy Yu, MedTech Actuator Origin alumna and Ventora Medical CTO, Forbes 30 Under 30

Key dates

  • Applications open: 6 Aug – 30 Sep
  • Finalists announced: 1 Oct
  • Online MedTech Actuator Origin Workshops: 7 Oct
  • Rapid Fire Round Pitch: 21 Oct
  • Mentoring and Sprint Intensive preparation: 22 Oct – 15 Nov
  • Sprint Intensive: 15 Nov – 17 Nov
  • Semi-finals Pitch: 17 Nov
  • MedTech Actuator Showcase and Finals Pitch: 9 Dec

Apply now

Are you ready to transform your idea and build your origin story – or do you know someone who is? Find out more about MedTech Actuator Origin and apply today.

Meet Gobind – Project Officer

Last year the MedTech ActuatorTM opened a second office – in Singapore. As part of our expansion through Asia Pacific, Project Officer Gobind Singh is supporting the work of Singapore-based founders to improve and save lives with health innovation.

As Project Officer Gobind helps to surround startups with the ecosystem support they need to bring their MedTech, HealthTech or BioTech innovation to the patients and clinicians who need it most.

With a focus on program delivery of the MedTech Actuator – Asia Pacific’s MedTech accelerator – Gobind connects startups with intensive mentorship, industry collaboration and capital raising support to help achieve in 15 months what can typically take 3 years or more.

“My role is where the MedTech Actuator’s rubber hits the road,” says Gobind. “I handle logistics, operations, communications, bookings and planning the program.”

Once the program begins, Gobind is the first point of contact for startups in Singapore. “I consult on their pitching, decks, IMs, strategy, and anything else they throw at me.”

Before joining the MedTech Actuator, Gobind was a fellow at the RMIT Health Transformation Lab where he broke down complex problems, generated new insights, and fostered new communities to help address the thorniest questions of health system reform, transformation, technology, and value.

In his role with the MedTech Actuator, Gobind is inspired by the success that startups can experience as a result of the program – and the human impact that having the right support can lead to.

“Watching startups succeed after taking feedback on board really inspires me,” says Gobind. “It makes me feel like I have contributed to the growth or commercialisation of the startups, which will in turn save human lives or make their recovery faster.”

Gobind has observed a common challenge experienced by MedTech startups in the process of commercialisation, with founders losing sight of the initial reasons that they began their trek down the entrepreneurial path.

“It is important to clarify, renew or even rework those initial aspirations as it will make the journey less bumpy – and the MedTech Actuator can help,” says Gobind.

“I am incredibly excited about the MedTech Actuator program’s growth to become the go-to MedTech accelerator in Asia Pacific.”

Find out more about MedTech Actuator – Asia Pacific’s MedTech accelerator.

NanoMSlide manufacturing smart microscope slides in Melbourne.

A new facility at the Australian National Fabrication Facility has made it possible for MedTech Actuator startup NanoMSlide to manufacture their smart nanotechnology microscope slides onshore for instant, more accurate cancer diagnosis.

Until now NanoMSlide has relied on overseas facilities for production of their invention. Housed at the Melbourne Centre for Nanofabrication Facility the new half-a-million dollar Phabler facility will enable industry, academia, and companies such as NanoMSlide to scale up production of nanoscale devices.

“With the Phabler facility we are now able to manufacture our slides right here in Melbourne and in quantities that will allow us to realise the full potential of our invention,” says NanoMSlide founder Professor Brian Abbey.

Current diagnostics of cancer in cells and tissues rely on chemicals, dyes, and extensive pre-processing of samples – taking valuable time and making accurate diagnosis more challenging. The new Phabler facility will make it possible for NanoMSlide to apply their patented nanopatterned coating to a conventional microscope slide, and create high-contrast images that instantly show the difference between cancerous and healthy cells.

NanoMSlide joined the MedTech Actuator in 2019 to develop their business model, connect with local and international partners and investors, build skills required to form a successful startup, and test their value proposition. The 15-month, industry-led, venture-backed program aggressively funds and accelerates medical, health and biological technology startups.

“One of the biggest challenges I faced in the MedTech Actuator was moving outside my comfort zone as a researcher,” says Brian. “As a startup founder you need to fulfil many roles and at the beginning I found pitching particularly hard. But as the program progressed I gained in confidence and experience.”

Brian is driven by the desire to improve outcomes for patients and to reduce the rate of misdiagnosis. Their invention is initially being used to diagnose early-stage breast cancer – and the team intend to scale for instant, more accurate diagnosis of other forms of cancer.

“As we are working on critical, life-changing problems, we constantly strive to develop our technology and deliver the best possible product,” says Brian.

The Medtech Actuator has connected the company with potential investors and industry partners. This dense innovation ecosystem is critical to success – Brian says it is important for MedTech entrepreneurs to seek advice from diverse experts and to be prepared to challenge your assumptions.

“We realised a few times in the MedTech Actuator that our initial plan was not ideal from a commercial perspective. While it was a difficult decision to change direction, the company is now in a much stronger position,” says Brian.

“I would recommend the MedTech Actuator to anyone with a great idea or potential product in the MedTech space – the community and support are fantastic and we had an unforgettable experience.”

Learn more about how the new Phabler tool is supporting NanoMSlide to manufacture their invention onshore and scale in this story from the Australian National Fabrication Facility.

La Trobe University aims to engage with industry partners and commercialise the NanoMSlide through a new spin-out company, AlleSense. Find out more.

Safeguarding frontline & essential workers from COVID-19 & future pandemics.

Expression of interest recently opened to invest in Soterius. The MedTech Actuator startup is scaling its COVID-19 biosensor to help protect workers and the wider community from devastating health, social and economic impacts of future pandemics.

The reliable, accurate and non-invasive Soterius biosensor delivers immediate results, informing whether an individual is required to test for infection and self-isolate or providing the all-clear to enter their work environment. The biosensor will initially be delivered to hospitals, with future applications in other frontline and essential worker settings including quarantine hotels, airports, and schools.

Emerging environmental viral sensors are bulky, energy intensive and specific to one virus. In contrast, the Soterius biosensor is so small that it fits on a personal fob card and is now scaling to detect other respiratory illnesses. Importantly, the biosensor is easy to use: individuals just swipe their card over a reader at checkpoints.

Prototype tests revealed that the biosensor detects SARS-CoV-2 spike protein in the picomolar range with impressive accuracy and reliability. SARS-CoV-2 is the virus responsible for COVID-19. This indicates that Soterius could be a top performing diagnostic for respiratory illnesses by immediately detecting the lowest presence of viral load.

Founded by Dr Alasdair Wood and Dr Chih Wei Teng, the Soterius biosensor is being developed in collaboration with the Burnet Institute, RMIT University, D+I and Vestech.

“In 2019, when the terms ‘social distancing’ and ‘stage 4 lockdown restrictions’ were unheard of, we observed inherent weaknesses in the world’s ability to protect itself against respiratory infection,” recalls Alasdair.

Alasdair and Chih Wei joined the MedTech Actuator – Asia Pacific’s MedTech catalyst – in 2019 to validate their ideas, connect with product designers and partners, and build the skills necessary for scaling their company.

“The MedTech Actuator is a complete package. You’re bound to learn and gain new perspectives, no matter how experienced you are,” says Chih Wei.

For Alasdair, the camaraderie and friendship amongst startups has also been a highlight.

“Peer learning is always great – we went through highs and lows together in a safe environment. I also love the people that populate the MedTech Actuator. The team is great and the people they bring in are amazing – including mentor Dr Elane Zelcer. Our new connections with peers, mentors and the wider ecosystem persist beyond the program,” says Alasdair.

“The MedTech Actuator provides the tools and connections to make ideas a reality, which is a very exciting proposition. But be ready to sprint!”

Reach out to Co-Founder and CEO Chih Wei Teng at chih(@)soterius.com.au to express interest in becoming a Soterius investor.

See the Soterius biosensor in this recent Channel 9 News story and read more about the technology and collaboration in this RMIT University media release.

Photo courtesy of RMIT University: Soterius sensors being prepared at RMIT University’s Micro Nano Research Facility for advanced manufacturing of cutting-edge electronics.

Asia Pacific’s best emerging health entrepreneurs join MedTech Actuator.

Entrepreneurs working to improve and save lives through health innovation have joined the MedTech Actuator – Asia Pacific’s MedTech catalyst.

We wish a warm welcome to our new cohort of clinicians, researchers and other changemakers with big plans to radically accelerate their medical, health or biological technology prototype or proof-of-concept:

  • GenEmbryomics: IVF Embryo Whole Genome Sequencing.
  • Gild: Improving healthcare access by developing gap-payment technology.
  • HatiSens: A handheld sensing device that can accurately diagnose heart attack in under 10 minutes.
  • Moon technologies: Providing emergency patients’ health data to paramedics in real-time.
  • Osteo-X: An internally self-locking intramedullary nail (orthopaedics) that reduces surgical time and radiation exposure.
  • Quitta: Developing safe, effective nicotine replacement therapies for the world’s 1.3 billion smokers.
  • The Mindful Mum (Rebranding to “Nourri”): A digital health platform that helps modern families nurture their health and happiness – for everyone’s benefit.
  • Virtetic: Empowering the prosthetics community through virtual reality.
  • XLR8: Developing wearable sensors and Rebee application to allow patients to perform physical rehabilitation exercises anywhere, any time.
  • Yabi: An innovative, accurate and automated method for monitoring and escalating surgical drain output.

The MedTech Actuator’s specialised acceleration model will surround the startups with the ecosystem support they need to bring their MedTech, HealthTech or BioTech innovation to the patients and clinicians who need it most.

Through MedTech Actuator’s intensive mentorship, industry collaboration, up to AUD$200K initial capital injection and capital raising support, the founders can achieve in 15 months what can typically take 3 years or more.

Embedded in the MedTech Actuator™ ecosystem, they will radically advance their technology development, raise seed capital, and build critical business and management skills. They will become primed and ready to grow their venture even further – including raising series A funding, commencing clinical trials, gaining regulatory approvals, and moving to at-scale manufacturing, and market launch.

Integrated across Asia Pacific, the industry-led MedTech Actuator will open an unrivalled network to founders, including 85 partners and 75 mentors from some of the largest names in health innovation spanning multi-national corporations, hospitals and clinicians, investor groups and VCs, professional service partners, universities and research institutions, and product development firms.

They will go on to join an alumni network of the brightest emerging startups from across Asia Pacific and our networks are their networks as they scale up, prepare for exit and beyond.

To follow founders and their journey sign up to our newsletter below and connect with us on LinkedIn and Twitter.

MedTech Actuator Menzies Scholarships applications open

Are you a researcher in MedTech, BioTech or HealthTech looking to explore entrepreneurship and commercialisation? Do you have a research project with market translation potential? Apply now for 2021 MedTech Actuator Menzies Scholarships!

Applications are now open for the 2021 MedTech Actuator Menzies Scholarships. Ten researchers will each receive a tailored learning experience, access to exclusive industry events and a one-off,  $1,000 stipend to explore entrepreneurship and commercialisation goals.  

Scholarships are available to high-potential scientists in MedTech, BioTech or HealthTech and researchers who may be undertaking their honours, masters, PhD or PostDoc – or perhaps have recently started working in industry. 

Scholarship recipients will be provided with unparalleled networking opportunities, leadership mentoring and insights into a career that fuses science, research, and entrepreneurship.

“Researchers make some of the most promising entrepreneurs – they are curious, natural problem solvers, humble and used to getting back on their feet after experiment failures.”
– Dr Buzz Palmer, CEO MedTech Actuator

The three-month scholarship will run from October to December and can be undertaken remotely while studying and working. Valued over $10,000, scholars will have access to the MedTech Actuator knowledge hub, online workshops, a three-day intensive from November 15 – 17 and the MedTech Actuator Showcase on December 9. 

“The MedTech Actuator Menzies Scholarship helped me improve my understanding of the MedTech industry, and I am already applying this new knowledge to our initiatives in women’s health technologies. I am extremely grateful to the MedTech Actuator and Menzies Foundation for providing me with this opportunity!”
Ritesh Warty, MedTech Actuator Menzies Scholar

Scholarship recipients will learn alongside Australia’s best emerging entrepreneurs competing in the MedTech Actuator Origin pitch competition. In the final month of the scholarship, recipients will attend the MedTech Actuator Showcase and network with the largest names in global MedTech corporates, clinicians, ecosystem VIPs and investors.

Beyond these unique insights and opportunities, scholarship recipients will gain an extensive overview of entrepreneurship, the startup ecosystem and the commercialisation process. Topics will include business modelling, pitching, intellectual property, product development, branding, path-to-market, and more.

The MedTech Actuator Menzies Scholarship will support the scientific community’s commercialisation capacity by facilitating knowledge transfer from industry to scientists and researchers.

If you are an academic or industry  scientist or researcher – or you know one – you can find out more about the scholarship and apply today.

Key dates:

  • Applications open July 5 – August 20
  • Shortlisted candidates notified August 25
  • Video interviews September 9
  • MedTech Actuator Menzies Scholarship outcomes released September 15
  • MedTech Actuator Menzies Scholarship Lunches October
  • MedTech Actuator Origin intensive November 15 – 17
  • MedTech Actuator Showcase Gala December 9

The MedTech Actuator Menzies Scholarship is supported by the Menzies Foundation as part of their Entrepreneurship in Science mission in partnership with the MedTech Actuator.

Apply now